BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murgo AJ. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist. 2001;6 Suppl 2:22-28. [PMID: 11331437 DOI: 10.1634/theoncologist.6-suppl_2-22] [Cited by in Crossref: 144] [Cited by in F6Publishing: 154] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1. Chem Biol Interact 2022;:110049. [PMID: 35872050 DOI: 10.1016/j.cbi.2022.110049] [Reference Citation Analysis]
2 Mirzaei A, Jahanshahi F, Khatami F, Reis LO, Aghamir SMK. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. Tissue Cell 2022;76:101805. [PMID: 35487055 DOI: 10.1016/j.tice.2022.101805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Das B, Pal A, Pal R, Kumar R, Das R, Dey D, Devi J, Sengupta M. Alteration in Inflammasome Cytokine Profile and Functional Plasticity of Macrophage Phenotype in Arsenic(0) Nanoparticle Treated Murine Fibrosarcoma. BioNanoSci . [DOI: 10.1007/s12668-021-00936-0] [Reference Citation Analysis]
4 Munir N, Jahangeer M, Bouyahya A, El Omari N, Ghchime R, Balahbib A, Aboulaghras S, Mahmood Z, Akram M, Ali Shah SM, Mikolaychik IN, Derkho M, Rebezov M, Venkidasamy B, Thiruvengadam M, Shariati MA. Heavy Metal Contamination of Natural Foods Is a Serious Health Issue: A Review. Sustainability 2022;14:161. [DOI: 10.3390/su14010161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
5 Li C, Zhang K, Liu A, Yue T, Wei Y, Zheng H, Piao JG, Li F. MMP2-responsive dual-targeting drug delivery system for valence-controlled arsenic trioxide prodrug delivery against hepatic carcinoma. Int J Pharm 2021;609:121209. [PMID: 34678398 DOI: 10.1016/j.ijpharm.2021.121209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ren C, Zhou Y, Liu W, Wang Q. Paradoxical effects of arsenic in the lungs. Environ Health Prev Med 2021;26:80. [PMID: 34388980 DOI: 10.1186/s12199-021-00998-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sönksen M, Kerl K, Bunzen H. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors. Med Res Rev 2021. [PMID: 34309879 DOI: 10.1002/med.21844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Borah G, Mudoi PP, Borah P. Arsenic contamination in water resources and its health risk assessment. Contamination of Water 2021. [DOI: 10.1016/b978-0-12-824058-8.00005-0] [Reference Citation Analysis]
9 Kenny C, Lucey B, Furey A. Adverse Human Health Effects and Regulation of Metal Contaminants in Terrestrial Plant‐Derived Food and Phytopharmaceuticals. Herbs, Spices and Medicinal Plants 2020. [DOI: 10.1002/9781119036685.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Fei W, Li C, Tao J, Cai X, Yao W, Ye Y, Zhang Y, Yao Y, Song Q, Li F, Zheng C. Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review. Int J Pharm 2020;583:119385. [PMID: 32376447 DOI: 10.1016/j.ijpharm.2020.119385] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Das B, Rahaman H, Ghosh SK, Sengupta M. Synthesis and Characterization of Arsenic(III) Oxide Nanoparticles as Potent Inhibitors of MCF 7 Cell Proliferation through Proapoptotic Mechanism. BioNanoSci 2020;10:420-9. [DOI: 10.1007/s12668-020-00726-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Lian Y, Wang X, Guo P, Li Y, Raza F, Su J, Qiu M. Erythrocyte Membrane-Coated Arsenic Trioxide-Loaded Sodium Alginate Nanoparticles for Tumor Therapy. Pharmaceutics 2019;12:E21. [PMID: 31878155 DOI: 10.3390/pharmaceutics12010021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
13 Wang Y, Jiang F, Jiao K, Ju L, Liu Q, Li Y, Miao L, Li Z. De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties. Exp Cell Res 2020;386:111739. [PMID: 31759055 DOI: 10.1016/j.yexcr.2019.111739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lyczko M, Lyczko K, Majkowska-Pilip A, Bilewicz A. 1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes-Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies. Molecules 2019;24:E3865. [PMID: 31717768 DOI: 10.3390/molecules24213865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vineetha VP, Raghu KG. An Overview on Arsenic Trioxide-Induced Cardiotoxicity. Cardiovasc Toxicol 2019;19:105-19. [PMID: 30617460 DOI: 10.1007/s12012-018-09504-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
16 Zhu Y, Chen W, Guan W, Fang Y, Hao C. Study of As 2 O 3 regulating proliferation and apoptosis of Tca8113 cells by inhibiting the expression of Id-1. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1932-7. [DOI: 10.1080/21691401.2019.1613419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Zdraljevic S, Fox BW, Strand C, Panda O, Tenjo FJ, Brady SC, Crombie TA, Doench JG, Schroeder FC, Andersen EC. Natural variation in C. elegans arsenic toxicity is explained by differences in branched chain amino acid metabolism. Elife 2019;8:e40260. [PMID: 30958264 DOI: 10.7554/eLife.40260] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
18 Lu Y, Liang Y, Zheng X, Deng X, Huang W, Zhang G. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma. J Exp Clin Cancer Res 2019;38:82. [PMID: 30770775 DOI: 10.1186/s13046-019-1077-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
19 Chi X, Zhang R, Zhao T, Gong X, Wei R, Yin Z, Lin H, Li D, Shan H, Gao J. Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma. Nanotechnology 2019;30:175101. [PMID: 30654348 DOI: 10.1088/1361-6528/aaff9e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
20 Wang S, Liu C, Wang C, Ma J, Xu H, Guo J, Deng Y. Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency. Asian J Pharm Sci 2020;15:365-73. [PMID: 32636954 DOI: 10.1016/j.ajps.2018.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Li J. Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines. Oncol Lett 2018;15:9392-6. [PMID: 29805662 DOI: 10.3892/ol.2018.8458] [Reference Citation Analysis]
22 Wu DD, Lau ATY, Yu FY, Cai NL, Dai LJ, Ok Kim M, Jin DY, Xu YM. Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide. Oncotarget 2017;8:49144-55. [PMID: 28467781 DOI: 10.18632/oncotarget.17100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
23 Li D, Du C, Lin Y, Wu M. Inhibition of Growth of Human Nasopharyngeal Cancer Xenografts in Scid Mice by Arsenic Trioxide. Tumori 2002;88:522-6. [DOI: 10.1177/030089160208800617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
24 Willems M, Dubois N, Musumeci L, Bours V, Robe PA. IκBζ: an emerging player in cancer. Oncotarget 2016;7:66310-22. [PMID: 27579619 DOI: 10.18632/oncotarget.11624] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
25 Hoonjan M, Jadhav V, Bhatt P. Arsenic trioxide: insights into its evolution to an anticancer agent. J Biol Inorg Chem 2018;23:313-29. [DOI: 10.1007/s00775-018-1537-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 17.5] [Reference Citation Analysis]
26 Cheng Y, Li Y, Ma C, Song Y, Xu H, Yu H, Xu S, Mu Q, Li H, Chen Y, Zhao G. Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction. Oncotarget 2016;7:12682-92. [PMID: 26871293 DOI: 10.18632/oncotarget.7259] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
27 Sheldon LA. Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein. Cell Cycle 2017;16:2058-72. [PMID: 28880708 DOI: 10.1080/15384101.2017.1338221] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
28 Peng Y, Zhao Z, Liu T, Li X, Hu X, Wei X, Zhang X, Tan W. Smart Human-Serum-Albumin-As2 O3 Nanodrug with Self-Amplified Folate Receptor-Targeting Ability for Chronic Myeloid Leukemia Treatment. Angew Chem Int Ed Engl 2017;56:10845-9. [PMID: 28686804 DOI: 10.1002/anie.201701366] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
29 Peng Y, Zhao Z, Liu T, Li X, Hu X, Wei X, Zhang X, Tan W. Smart Human-Serum-Albumin-As 2 O 3 Nanodrug with Self-Amplified Folate Receptor-Targeting Ability for Chronic Myeloid Leukemia Treatment. Angew Chem 2017;129:10985-9. [DOI: 10.1002/ange.201701366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhang Z, Liu H, Zhou H, Zhu X, Zhao Z, Chi X, Shan H, Gao J. A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment. Nanoscale 2016;8:4373-80. [PMID: 26840759 DOI: 10.1039/c5nr07860a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
31 Parker LJ, Bocedi A, Ascher DB, Aitken JB, Harris HH, Lo Bello M, Ricci G, Morton CJ, Parker MW. Glutathione transferase P1-1 as an arsenic drug-sequestering enzyme. Protein Sci 2017;26:317-26. [PMID: 27863446 DOI: 10.1002/pro.3084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
32 Sattar A, Xie S, Hafeez MA, Wang X, Hussain HI, Iqbal Z, Pan Y, Iqbal M, Shabbir MA, Yuan Z. Metabolism and toxicity of arsenicals in mammals. Environmental Toxicology and Pharmacology 2016;48:214-24. [DOI: 10.1016/j.etap.2016.10.020] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 15.3] [Reference Citation Analysis]
33 Akhtar A, Xiaoyan Wang S, Ghali L, Bell C, Wen X. Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers. J Biomed Res 2017;31:177-88. [PMID: 28808212 DOI: 10.7555/JBR.31.20160059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
34 Liu H, Zhang Z, Chi X, Zhao Z, Huang D, Jin J, Gao J. Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells. Sci Rep 2016;6:31009. [PMID: 27484730 DOI: 10.1038/srep31009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
35 Chen F, Yi J, Gu Z, Tang B, Li J, Li L, Kulkarni P, Liu L, Mason RP, Tang Q. Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study. Nanoscale 2016;8:6094-100. [DOI: 10.1039/c6nr00536e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
36 Zhang H, Gu H, Li L, Ren Y, Zhang L. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway. Tumour Biol 2016;37:5919-23. [PMID: 26592252 DOI: 10.1007/s13277-015-4463-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Zhao YY, Yu L, Liu BL, He XJ, Zhang BY. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol Med Rep 2015;12:7335-43. [PMID: 26459009 DOI: 10.3892/mmr.2015.4367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
38 You D, Kim Y, Jang MJ, Lee C, Jeong IG, Cho YM, Hwang JJ, Hong JH, Ahn H, Kim CS. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway. PLoS One 2015;10:e0137589. [PMID: 26352139 DOI: 10.1371/journal.pone.0137589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
39 Zhang X, Lu J, Ren X, Du Y, Zheng Y, Ioannou PV, Holmgren A. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1. Free Radic Biol Med 2015;89:192-200. [PMID: 26169724 DOI: 10.1016/j.freeradbiomed.2015.07.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
40 Shooshtary S, Behtash S, Nafisi S. Arsenic trioxide binding to serum proteins. J Photochem Photobiol B 2015;148:31-6. [PMID: 25863441 DOI: 10.1016/j.jphotobiol.2015.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
41 Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exp Suppl. 2012;101:133-164. [PMID: 22945569 DOI: 10.1007/978-3-7643-8340-4_6] [Cited by in Crossref: 1977] [Cited by in F6Publishing: 911] [Article Influence: 282.4] [Reference Citation Analysis]
42 Zhao H, Sun G, Kong D, Zhang Y, Shi W, Zhao M, Hong L, Qiao Z. A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma. Med Oncol 2015;32:79. [PMID: 25698531 DOI: 10.1007/s12032-015-0526-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Islam LN. Immunotoxic Effects of Arsenic Exposure. Handbook of Arsenic Toxicology. Elsevier; 2015. pp. 493-519. [DOI: 10.1016/b978-0-12-418688-0.00021-6] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ma W, Zhao L, Yin K, Feng D, Yang F, Liang J, Chen H, Bi C, Li X, Wang Y, Cai B. Effects of arsenic trioxide on proliferation, paracrine and migration of cardiac progenitor cells. Int J Cardiol 2015;179:393-6. [PMID: 25464494 DOI: 10.1016/j.ijcard.2014.11.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Ding W, Zhang L, Kim S, Tian W, Tong Y, Liu J, Ma Y, Chen S. Arsenic sulfide as a potential anti‑cancer drug. Mol Med Rep 2015;11:968-74. [PMID: 25371265 DOI: 10.3892/mmr.2014.2838] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
46 Gwak HS, Park MJ, Park IC, Woo SH, Jin HO, Rhee CH, Jung HW. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation. J Neurosurg 2014;121:1483-91. [PMID: 25303017 DOI: 10.3171/2014.8.JNS131991] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
47 Zhang H, Luo M, Liang X, Wang D, Gu X, Duan C, Gu H, Chen G, Zhao X, Zhao Z, Liu C. Galectin-3 as a marker and potential therapeutic target in breast cancer. PLoS One 2014;9:e103482. [PMID: 25254965 DOI: 10.1371/journal.pone.0103482] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
48 Ma ZB, Xu HY, Jiang M, Yang YL, Liu LX, Li YH. Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells. World J Gastroenterol 2014; 20(18): 5505-5510 [PMID: 24833880 DOI: 10.3748/wjg.v20.i18.5505] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
49 Giles FJ, Kantarjian H, Cortes J. Novel therapies for patients with chronic myeloid leukemia. Expert Review of Anticancer Therapy 2014;4:271-82. [DOI: 10.1586/14737140.4.2.271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
50 Chen M, Carkner R, Buttyan R. The hedgehog/Gli signaling paradigm in prostate cancer. Expert Rev Endocrinol Metab 2011;6:453-67. [PMID: 21776292 DOI: 10.1586/EEM.11.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 25] [Article Influence: 0.5] [Reference Citation Analysis]
51 Chen M, Carkner R, Buttyan R. The hedgehog/Gli signaling paradigm in prostate cancer. Expert Review of Endocrinology & Metabolism 2014;6:453-67. [DOI: 10.1586/eem.11.24] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
52 Kim EY, Lee SS, Shin JH, Kim SH, Shin DH, Baek SY. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model. Clin Exp Med 2014;14:215-24. [PMID: 23467906 DOI: 10.1007/s10238-013-0233-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
53 Liu D, Zhi D, Zhou T, Yu Q, Wan F, Bai Y, Li H. Realgar bioleaching solution is a less toxic arsenic agent in suppressing the Ras/MAPK pathway in Caenorhabditis elegans. Environmental Toxicology and Pharmacology 2013;35:292-9. [DOI: 10.1016/j.etap.2013.01.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
54 Alarifi S, Ali D, Alkahtani S, Siddiqui MA, Ali BA. Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells. Onco Targets Ther 2013;6:75-84. [PMID: 23404534 DOI: 10.2147/OTT.S38227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
55 Irwin ME, Rivera-Del Valle N, Chandra J. Redox control of leukemia: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2013;18:1349-83. [PMID: 22900756 DOI: 10.1089/ars.2011.4258] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 9.3] [Reference Citation Analysis]
56 Alhasan MK, Liu L, Lewis MA, Magnusson J, Mason RP. Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors. PLoS One 2012;7:e46106. [PMID: 23029403 DOI: 10.1371/journal.pone.0046106] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
57 Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exp Suppl 2012;101:133-64. [PMID: 22945569 DOI: 10.1007/978-3-7643-8340-4_6] [Cited by in Crossref: 1646] [Cited by in F6Publishing: 1] [Article Influence: 164.6] [Reference Citation Analysis]
58 Ren Q, Tey J, Li X, Wu Y, Deng H, Han L. Radiosensitization of cervical cancer xenografts by arsenic trioxide and the role of VEGF and Ku70. J Radiat Oncol 2012;1:299-304. [DOI: 10.1007/s13566-012-0004-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Nielsen FH. Manganese, Molybdenum, Boron, Chromium, and Other Trace Elements. In: Erdman JW, Macdonald IA, Zeisel SH, editors. Present Knowledge in Nutrition. Oxford: Wiley-Blackwell; 2012. pp. 586-607. [DOI: 10.1002/9781119946045.ch38] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
60 Yih LH, Hsu NC, Kuo HH, Wu YC. Inhibition of the heat shock response by PI103 enhances the cytotoxicity of arsenic trioxide. Toxicol Sci 2012;128:126-36. [PMID: 22496356 DOI: 10.1093/toxsci/kfs130] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
61 Seong NJ, Yoon CJ, Kang SG, Chung JW, Kim HC, Park JH. Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administration. Korean J Radiol 2012;13:195-201. [PMID: 22438687 DOI: 10.3348/kjr.2012.13.2.195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
62 Muenyi CS, Pinhas AR, Fan TW, Brock GN, Helm CW, States JC. Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses. Toxicol Sci 2012;127:139-49. [PMID: 22331493 DOI: 10.1093/toxsci/kfs085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
63 Anwar-mohammed A, El-kadi AOS. Modulation of AHR Function by Heavy Metals and Disease States. The AH Receptor in Biology and Toxicology 2011. [DOI: 10.1002/9781118140574.ch25] [Reference Citation Analysis]
64 Zelenik Pevec A, Šlejkovec Z, van Elteren JT, Falnoga I. As2O3 oxidation by vitamin C: cell culture studies. Biometals 2012;25:103-13. [DOI: 10.1007/s10534-011-9486-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
65 Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123:305-332. [PMID: 21750349 DOI: 10.1093/toxsci/kfr184] [Cited by in Crossref: 782] [Cited by in F6Publishing: 799] [Article Influence: 71.1] [Reference Citation Analysis]
66 Muenyi CS, States VA, Masters JH, Fan TW, Helm CW, States JC. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). J Ovarian Res. 2011;4:9. [PMID: 21696631 DOI: 10.1186/1757-2215-4-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
67 Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 2011;32:179-88. [PMID: 20857258 DOI: 10.1007/s13277-010-0111-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
68 Pucer A, Castino R, Mirković B, Falnoga I, Slejkovec Z, Isidoro C, Lah TT. Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells. Biol Chem 2010;391:519-31. [PMID: 20302512 DOI: 10.1515/BC.2010.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
69 Ahn RW, Chen F, Chen H, Stern ST, Clogston JD, Patri AK, Raja MR, Swindell EP, Parimi V, Cryns VL, O'Halloran TV. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer. Clin Cancer Res 2010;16:3607-17. [PMID: 20519360 DOI: 10.1158/1078-0432.CCR-10-0068] [Cited by in Crossref: 84] [Cited by in F6Publishing: 93] [Article Influence: 7.0] [Reference Citation Analysis]
70 Stevens JJ, Graham B, Walker AM, Tchounwou PB, Rogers C. The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cells. Int J Environ Res Public Health 2010;7:2018-32. [PMID: 20623008 DOI: 10.3390/ijerph7052018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
71 Ting H, Yen C, Chen W, Chang W, Chou M, Lu F. Humic acid enhances the cytotoxic effects of arsenic trioxide on human cervical cancer cells. Environmental Toxicology and Pharmacology 2010;29:117-25. [DOI: 10.1016/j.etap.2009.11.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
72 Huang HS, Liu ZM, Hong DY. Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes. Toxicol Appl Pharmacol 2010;244:234-41. [PMID: 20074581 DOI: 10.1016/j.taap.2009.12.037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
73 Duan X, Wu Y, Xu H, Zhao M, Zhuang H, Wang X, Yan H, Chen G. Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes. Chemico-Biological Interactions 2010;183:222-30. [DOI: 10.1016/j.cbi.2009.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
74 Gore L. Molecularly Targeted Therapies in Pediatric Myelodysplastic Syndromes. Molecularly Targeted Therapy for Childhood Cancer 2010. [DOI: 10.1007/978-0-387-69062-9_9] [Reference Citation Analysis]
75 You EA, Ahn RW, Lee MH, Raja MR, O'Halloran TV, Odom TW. Size control of arsenic trioxide nanocrystals grown in nanowells. J Am Chem Soc 2009;131:10863-5. [PMID: 19624123 DOI: 10.1021/ja902117b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
76 Kwong RC, Karagas MR, Kelsey KT, Mason RA, Tanyos SA, Schned AR, Marsit CJ, Andrew AS. Arsenic exposure predicts bladder cancer survival in a US population. World J Urol 2010;28:487-92. [PMID: 19834714 DOI: 10.1007/s00345-009-0477-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
77 Sui H, Bai Y, Han Y, Wang K. Arsenic trioxide enhances the therapeutic efficacy of adjuvant post-operative chemotherapy of gastric carcinoma while protecting bone marrow. Chin -Ger J Clin Oncol 2009;8:406-410. [DOI: 10.1007/s10330-009-0034-6] [Reference Citation Analysis]
78 Bachleitner-hofmann T, Kees M, Gisslinger H. Arsenic Trioxide: Acute Promyelocytic Leukemia and Beyond. Leukemia & Lymphoma 2009;43:1535-40. [DOI: 10.1080/1042819021000002857] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
79 Vivas-Mejía PE, Ozpolat B, Chen X, Lopez-Berestein G. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Int J Cancer 2009;125:264-75. [PMID: 19408305 DOI: 10.1002/ijc.24341] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
80 Lin T, Lu F, Yin Y, Tseng T. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Chemico-Biological Interactions 2009;180:61-8. [DOI: 10.1016/j.cbi.2009.01.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
81 Anwar-mohamed A, Elbekai RH, El-kadi AO. Regulation of CYP1A1 by heavy metals and consequences for drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 2009;5:501-21. [DOI: 10.1517/17425250902918302] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
82 Doyle D. Notoriety to respectability: a short history of arsenic prior to its present day use in haematology. British Journal of Haematology 2009;145:309-17. [DOI: 10.1111/j.1365-2141.2009.07623.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
83 Chang JE, Voorhees PM, Kolesar JM, Ahuja HG, Sanchez FA, Rodriguez GA, Kim K, Werndli J, Bailey HH, Kahl BS. Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study. Hematol Oncol 2009;27:11-6. [PMID: 18668698 DOI: 10.1002/hon.870] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
84 Duan Q, Komissarova E, Dai W. Arsenic trioxide suppresses paclitaxel-induced mitotic arrest. Cell Prolif 2009;42:404-11. [PMID: 19397590 DOI: 10.1111/j.1365-2184.2009.00606.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
85 Liu XM, Xiong XF, Song Y, Tang RJ, Liang XQ, Cao EH. Possible roles of a tumor suppressor gene PIG11 in hepatocarcinogenesis and As2O3-induced apoptosis in liver cancer cells. J Gastroenterol. 2009;44:460-469. [PMID: 19333544 DOI: 10.1007/s00535-009-0030-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
86 Bairey O, Vanichkin A, Shpilberg O. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells. Int J Lab Hematol 2010;32:e77-85. [PMID: 19208092 DOI: 10.1111/j.1751-553X.2008.01134.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
87 Helm CW, States JC. Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role. J Ovarian Res 2009;2:2. [PMID: 19144189 DOI: 10.1186/1757-2215-2-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 4.8] [Reference Citation Analysis]
88 Rosenblatt AE, Burnstein KL. Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic. Mol Endocrinol 2009;23:412-21. [PMID: 19131511 DOI: 10.1210/me.2008-0235] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
89 Bae-jump VL, Chunxiao Zhou, Boggess JF, Gehrig PA. Arsenic Trioxide (As2O3) Inhibits Expression of Estrogen Receptor—alpha Through Regulation of the Mitogen-activated Protein Kinase (MAPK) Pathway in Endometrial Cancer Cells. Reprod Sci 2008;15:1011-7. [DOI: 10.1177/1933719108324134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ganguli S, Goldberg SN. Radiofrequency equipment and scientific basis for radiofrequency ablation. Interventional Radiological Treatment of Liver Tumors 2008. [DOI: 10.1017/cbo9780511575433.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Krishna R, Sorour Y, Goepel JR, Kirkbride P, Smith DJ, Ezaydi Y, Dalley CD, Snowden JA. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia. Clin Oncol (R Coll Radiol) 2008;20:769-71. [PMID: 18995171 DOI: 10.1016/j.clon.2008.10.004] [Reference Citation Analysis]
92 Xiao YF, Wu DD, Liu SX, Chen X, Ren LF. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol. 2007;13:6498-6505. [PMID: 18161919 DOI: 10.3748/wjg.13.6498] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
93 Kim J, Bae J, Lee S, Lee E, Chung B, Kim S, Kang C. Induction of NKG2D Ligands and Subsequent Enhancement of NK Cell-mediated Lysis of Cancer Cells by Arsenic Trioxide. Journal of Immunotherapy 2008;31:475-86. [DOI: 10.1097/cji.0b013e3181755deb] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
94 Taylor BF, McNeely SC, Miller HL, States JC. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. Toxicol Appl Pharmacol 2008;230:235-46. [PMID: 18485433 DOI: 10.1016/j.taap.2008.02.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
95 Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008;8:58. [PMID: 18294404 DOI: 10.1186/1471-2407-8-58] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
96 McNeely SC, Belshoff AC, Taylor BF, Fan TW, McCabe MJ Jr, Pinhas AR, States JC. Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest. Toxicol Appl Pharmacol 2008;229:252-61. [PMID: 18328521 DOI: 10.1016/j.taap.2008.01.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
97 Liu ZM, Huang HS. Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression. J Biomed Sci 2008;15:333-42. [PMID: 18210215 DOI: 10.1007/s11373-007-9232-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
98 Altman JK, Yoon P, Katsoulidis E, Kroczynska B, Sassano A, Redig AJ, Glaser H, Jordan A, Tallman MS, Hay N, Platanias LC. Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses. Journal of Biological Chemistry 2008;283:1992-2001. [DOI: 10.1074/jbc.m705227200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
99 Xiao YF, Wu DD, Liu SX, Chen X, Ren LF. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol 2007; 13(48): 6498-6505 [PMID: 18161919 DOI: 10.3748/wjg.v13.i48.6498] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
100 Chen G, Wang Q, Yan H, Chen Z. Arsenic Trioxide and Leukemia. Natural Products. [DOI: 10.1007/978-1-59259-976-9_11] [Reference Citation Analysis]
101 Chai CY, Huang YC, Hung WC, Kang WY, Chen WT. Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicol Lett 2007;173:48-56. [PMID: 17683884 DOI: 10.1016/j.toxlet.2007.06.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
102 Peng Z, Peng L, Fan Y, Zandi E, Shertzer HG, Xia Y. A critical role for IkappaB kinase beta in metallothionein-1 expression and protection against arsenic toxicity. J Biol Chem 2007;282:21487-96. [PMID: 17526490 DOI: 10.1074/jbc.M702510200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
103 Falnoga I, Šlejkovec Z, Pucer A, Podgornik H, Tušek-žnidarič M. Arsenic metabolism in multiple myeloma and astrocytoma cells. Biol Trace Elem Res 2007;116:5-28. [DOI: 10.1007/bf02685915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
104 Qian W, Liu J, Jin J, Ni W, Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leukemia Research 2007;31:329-39. [DOI: 10.1016/j.leukres.2006.06.021] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 9.9] [Reference Citation Analysis]
105 Cheung WM, Chu PW, Kwong YL. Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells. Cancer Letters 2007;246:122-8. [DOI: 10.1016/j.canlet.2006.02.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
106 Olivier S, Robe P, Bours V. Can NF-κB be a target for novel and efficient anti-cancer agents? Biochemical Pharmacology 2006;72:1054-68. [DOI: 10.1016/j.bcp.2006.07.023] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
107 Xiao YF, Liu SX, Wu DD, Chen X, Ren LF. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World J Gastroenterol 2006; 12(36): 5780-5786 [PMID: 17007042 DOI: 10.3748/wjg.v12.i36.5780] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
108 Elbekai RH, Duke J, El-Kadi AO. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As(3+), Cd(2+) and Cr(6+). Cancer Lett 2007;246:54-62. [PMID: 16517059 DOI: 10.1016/j.canlet.2006.01.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
109 Sekeres MA. Arsenic trioxide as a treatment for myelodysplastic syndrome. Curr Hematol Malig Rep 2006;1:34-8. [DOI: 10.1007/s11899-006-0015-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
110 Liu Z, Huang H. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. Cellular Signalling 2006;18:244-55. [DOI: 10.1016/j.cellsig.2005.04.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
111 Gibaud S, Alfonsi R, Mutzenhardt P, Fries I, Astier A. (2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity. Journal of Organometallic Chemistry 2006;691:1081-4. [DOI: 10.1016/j.jorganchem.2005.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
112 Wyllie S, Fairlamb AH. Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell line. Biochem Pharmacol 2006;71:257-67. [PMID: 16318845 DOI: 10.1016/j.bcp.2005.10.043] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
113 Huang H, Liu Z, Ding L, Chang W, Hsu P, Wang S, Chi C, Chuang C. Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity. J Biomed Sci 2006;13:113-25. [DOI: 10.1007/s11373-005-9040-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
114 Nafisi S, Sobhanmanesh A, Alimoghaddam K, Ghavamzadeh A, Tajmir-Riahi HA. Interaction of arsenic trioxide As2O3 with DNA and RNA. DNA Cell Biol 2005;24:634-40. [PMID: 16225394 DOI: 10.1089/dna.2005.24.634] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
115 Kim J, Bae SM, Lim DS, Kwak SY, Lee CK, Lee YS, Bae IJ, Yoo JY, Lee YJ, Kim CK, Ahn WS. Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa. Cancer Res Treat 2005;37:307-12. [PMID: 19956532 DOI: 10.4143/crt.2005.37.5.307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
116 Chou WC, Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 2005;12:1-6. [PMID: 15604884 DOI: 10.1097/01.moh.0000148552.93303.45] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]
117 Griffin RJ, Williams BW, Park HJ, Song CW. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. International Journal of Radiation Oncology*Biology*Physics 2005;61:1516-22. [DOI: 10.1016/j.ijrobp.2004.12.058] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
118 Diaz Z, Colombo M, Mann KK, Su H, Smith KN, Bohle DS, Schipper HM, Miller WH. Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines. Blood 2005;105:1237-45. [DOI: 10.1182/blood-2004-05-1772] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
119 Karasavvas N, Cárcamo JM, Stratis G, Golde DW. Vitamin C protects HL60 and U266 cells from arsenic toxicity. Blood 2005;105:4004-12. [PMID: 15677571 DOI: 10.1182/blood-2003-03-0772] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
120 Yang J, Li H, Chen Y, Wang X, Shi G, Hu Q, Kang X, Lu Y, Tang X, Guo Q, Yi J. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radical Biology and Medicine 2004;37:2027-41. [DOI: 10.1016/j.freeradbiomed.2004.09.016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.3] [Reference Citation Analysis]
121 Ho S. Metal Ions as Endocrine Disruptors. Endocrine Disruptors 2004. [DOI: 10.1201/9781420038866.ch13] [Reference Citation Analysis]
122 Wei L, Lai K, Chen C, Cheng C, Huang Y, Chou C, Kuo M, Hsieh C. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB. Oncogene 2005;24:390-8. [DOI: 10.1038/sj.onc.1208192] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
123 Ning S, Knox SJ. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. International Journal of Radiation Oncology*Biology*Physics 2004;60:197-203. [DOI: 10.1016/j.ijrobp.2004.02.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
124 Liang XQ, Cao EH, Zhang Y, Qin JF. A P53 target gene, PIG11, contributes to chemosensitivity of cells to arsenic trioxide. FEBS Lett 2004;569:94-8. [PMID: 15225615 DOI: 10.1016/j.febslet.2004.05.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
125 Griffin RJ, Monzen H, Williams BW, Park H, Lee SH, Song CW. Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours. Int J Hyperthermia 2003;19:575-89. [PMID: 14756449 DOI: 10.1080/0265673031000124316] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
126 Kim YW, Bae SM, Lee KH, Lee JM, Namkoong SE, Lee IP, Kim CK, Seo JS, Sin JI, Kim YW, Ahn WS. Comparison of As(2)O(3) and As(4)O(6) in the detection of SiHa cervical cancer cell growth inhibition pathway. Cancer Res Treat 2004;36:255-62. [PMID: 20368843 DOI: 10.4143/crt.2004.36.4.255] [Reference Citation Analysis]
127 Cortes JE, O'brien SM, Giles F, Alvarez RH, Talpaz M, Kantarjian H. Investigational strategies in chronic myelogenous leukemia. Hematology/Oncology Clinics of North America 2004;18:619-39. [DOI: 10.1016/j.hoc.2004.03.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
128 Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J, Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay M, Slamon DJ. Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer. JNCI Journal of the National Cancer Institute 2004;96:759-69. [DOI: 10.1093/jnci/djh133] [Cited by in Crossref: 221] [Cited by in F6Publishing: 226] [Article Influence: 12.3] [Reference Citation Analysis]
129 Tchounwou PB, Patlolla AK, Centeno JA. Carcinogenic and systemic health effects associated with arsenic exposure--a critical review. Toxicol Pathol 2003;31:575-88. [PMID: 14585726 DOI: 10.1080/01926230390242007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 108] [Article Influence: 2.4] [Reference Citation Analysis]
130 Fernández C, Ramos AM, Sancho P, Amrán D, de Blas E, Aller P. 12-O-Tetradecanoylphorbol-13-acetate May Both Potentiate and Decrease the Generation of Apoptosis by the Antileukemic Agent Arsenic Trioxide in Human Promonocytic Cells. Journal of Biological Chemistry 2004;279:3877-84. [DOI: 10.1074/jbc.m310665200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
131 Mathas S, Lietz A, Janz M, Hinz M, Jundt F, Scheidereit C, Bommert K, Dörken B. Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis. Blood 2003;102:1028-34. [DOI: 10.1182/blood-2002-04-1154] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 6.7] [Reference Citation Analysis]
132 Ryoo JJ, Cole CE, Anderson KC. Novel therapies for multiple myeloma. Blood Rev 2002;16:167-74. [PMID: 12163002 DOI: 10.1016/s0268-960x(02)00009-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
133 Wysocki R, Clemens S, Augustyniak D, Golik P, Maciaszczyk E, Tamás MJ, Dziadkowiec D. Metalloid tolerance based on phytochelatins is not functionally equivalent to the arsenite transporter Acr3p. Biochemical and Biophysical Research Communications 2003;304:293-300. [DOI: 10.1016/s0006-291x(03)00584-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
134 Stull DM. Targeted therapies for the treatment of leukemia. Seminars in Oncology Nursing 2003;19:90-7. [DOI: 10.1016/s0749-2081(03)00005-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
135 Tipping AJ, Melo JV. Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies. Seminars in Hematology 2003;40:83-91. [DOI: 10.1053/shem.2003.50047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
136 Filippova M, Duerksen-hughes PJ. Inorganic and Dimethylated Arsenic Species Induce Cellular p53. Chem Res Toxicol 2003;16:423-31. [DOI: 10.1021/tx025606a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
137 Duyndam MC, Hulscher ST, van der Wall E, Pinedo HM, Boven E. Evidence for a Role of p38 Kinase in Hypoxia-inducible Factor 1-independent Induction of Vascular Endothelial Growth Factor Expression by Sodium Arsenite. Journal of Biological Chemistry 2003;278:6885-95. [DOI: 10.1074/jbc.m206320200] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.4] [Reference Citation Analysis]
138 Vernhet L, Allain N, Le Vée M, Morel F, Guillouzo A, Fardel O. Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther 2003;304:145-55. [PMID: 12490585 DOI: 10.1124/jpet.102.042176] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
139 Lecureur V, Le Thiec A, Le Meur A, Amiot L, Drenou B, Bernard M, Lamy T, Fauchet R, Fardel O. Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells. Br J Haematol. 2002;119:608-615. [PMID: 12437633 DOI: 10.1046/j.1365-2141.2002.03863.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
140 Slack JL, Waxman S, Tricot G, Tallman MS, Bloomfield CD. Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide. Oncologist. 2002;7 Suppl 1:1-13. [PMID: 11961204 DOI: 10.1634/theoncologist.7-suppl_1-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
141 Um S, Lee S, Kim E, Myoung J, Namkoong S, Park J. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells. Cancer Letters 2002;181:11-22. [DOI: 10.1016/s0304-3835(02)00039-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
142 La Rosée P, Johnson K, O'dwyer ME, Druker BJ. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia. Experimental Hematology 2002;30:729-37. [DOI: 10.1016/s0301-472x(02)00836-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
143 Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, Shinjo K, Fujita Y, Matsui H, Sahara N, Takeshita A, Satoh H, Terada H, Ohno R. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia 2002;16:617-22. [DOI: 10.1038/sj.leu.2402426] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 4.0] [Reference Citation Analysis]
144 Gao F, Yi J, Shi GY, Li H, Shi XG, Tang XM. The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species. World J Gastroenterol 2002; 8(1): 36-39 [PMID: 11833067 DOI: 10.3748/wjg.v8.i1.36] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
145 Duyndam MC, Hulscher TM, Fontijn D, Pinedo HM, Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem 2001;276:48066-76. [PMID: 11641398 DOI: 10.1074/jbc.M106282200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 4.1] [Reference Citation Analysis]